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Discussion
Dr Abe DeAnda, Jr (New York, NY). Dr Lee, I want to thank
you for sharing your report with me ahead of time and congratulate
you on this nice study. You have addressed a problem and have a
well-designed study to try to glean out some information.
I have 2 questions. I hope you can give us further insight.
As you mentioned, what we use in the operating room now is
either a 4-channel or an 8-channel NIRS system. This system
presented in your study uses 270 channels. This is NIRS on
steroids. Yet, most of us in this room probably do not know how
to interpret what we have now at 4 channels or 8 channels, and
sometimes we have an anesthesiologist who might be able to
interpret what we are seeing, often after the fact. Some of the
monitors will give you a breakdown (ie, printout) of the data after
the fact. So my first question is, would it be reasonable that we are
going to know what to do with these data intraoperatively in real
time when we do not know how to do it with 4 channels?
The second one is, it is a very nice model of transient ischemic
attacks and you did have the SAH in 2 cases. That is not what we
are normally seeing, even when we are doing arch surgery. We
are seeing somebody who postoperatively has perhaps some neuro-
cognitive dysfunction seen only with high-grade testing when you
give them a battery of tests to search for the dysfunction. It can be
very, very subtle. That is because the insult can be very, very subtle.
Is the fidelity or the sensitivity of this type of monitoring able to
detect those small changes rather than these large changes?
Dr Lee. Thank you, Dr DeAnda, for this very insightful
discussion.
Your questions relating to the ability to interpret intraoperative
data and the sensitivity of this technology are germane to its poten-
tial clinical utility. It is true that the hemorrhage and ischemia that
my presentation primarily focused on were large-magnitude he-
modynamic perturbations, and that the hemorrhage was spatially
extensive. However, this imaging technology is sensitive enough
to detect hemoglobin concentration changes of just a few micro-
molar. In addition, it can detect them at the instrumentation’s sam-
pling rate, which was 8 images per second for these experiments,
but can be even higher for more recently developed devices.
As far as whether this technology will be able to pick up on, say,
subtle insults that lead to cognitive dysfunction, and whether real-
time interpretation in the operating room will be possible, we will
need to perform human studies to answer those questions. That
will allow us to determine how successfully we can identify intra-
operative ‘‘biomarkers’’ in the fNIRS data that correlate with subse-
quent neurological complications. In terms of the instrument and the
technology, it is very sensitive and detects very minor, fast changes,
as I’ve indicated. For example, as I have shown, even with a little bit
of injected contrast, very obvious changes were noted, in real time.
In summary, I think that this technology is promising. In order
to determine its effectiveness, we would have to do human studies
comparing the preoperative and postoperative neurological and
cognitive statuses, and looking at what we see in the operating
room. Then we will have a systematic assessment of its utility.gery c December 2014
